Department of Gynecology, Meizhou People's Hospital (Meizhou Academy of Medical Sciences), Meizhou, Guangdong, China.
J Obstet Gynaecol Res. 2023 Oct;49(10):2468-2474. doi: 10.1111/jog.15749. Epub 2023 Jul 24.
Some studies have reported that the prognosis of total laparoscopic hysterectomy (TLH) for early-stage cervical cancer (CC) is worse than that of open surgery. And this was associated with the use of uterine manipulator or not. Therefore, this study retrospectively analyzes the efficacy and safety of TLH without uterine manipulator combined with pelvic lymphadenectomy for early-stage CC.
Fifty-eight patients with CC (stage IB1-IIA1) who received radical hysterectomy from September 2019 to January 2020 were divided into no uterine manipulator (n = 26) and uterine manipulator group (n = 32). Then, clinical characteristics were collected and intraoperative/postoperative related indicators were compared.
Patients in the no uterine manipulator group had significantly higher operation time and blood loss than in the uterine manipulator group. Notably, there was no significant difference in hemoglobin change, blood transfusion rate, number of pelvic nodules, anal exhaust time, complications and recurrence rate between the two groups. Additionally, patients in the uterine manipulator group were prone to urinary retention (15.6%) and lymphocyst (12.5%), while the no uterine manipulator group exhibited high probability of bladder dysfunction (23.1%) and urinary retention (15.4%). Furthermore, the 1-year disease-free survival rate and the 1-year overall survival rate were not significantly different between the two groups.
There was no significant difference in the efficacy and safety of TLH with or without uterine manipulator combined with pelvic lymphadenectomy in the treatment of patients with early-stage CC. However, the latter requires consideration of the negative effects of high operation time and blood loss.
一些研究报道称,早期宫颈癌(CC)全腹腔镜子宫切除术(TLH)的预后比开放手术差。这与是否使用子宫操纵器有关。因此,本研究回顾性分析了不使用子宫操纵器联合盆腔淋巴结清扫术治疗早期 CC 的 TLH 的疗效和安全性。
2019 年 9 月至 2020 年 1 月,58 例接受根治性子宫切除术的 CC(IB1-IIA1 期)患者分为无子宫操纵器组(n=26)和子宫操纵器组(n=32)。然后收集临床特征,并比较术中/术后相关指标。
无子宫操纵器组的手术时间和出血量明显高于子宫操纵器组。值得注意的是,两组间血红蛋白变化、输血率、盆腔结节数、肛门排气时间、并发症和复发率均无显著差异。此外,子宫操纵器组易发生尿潴留(15.6%)和淋巴囊肿(12.5%),而无子宫操纵器组膀胱功能障碍(23.1%)和尿潴留(15.4%)的发生率较高。此外,两组患者的 1 年无病生存率和 1 年总生存率无显著差异。
TLH 联合或不联合盆腔淋巴结清扫术治疗早期 CC 的疗效和安全性无显著差异。但后者需要考虑手术时间长和出血量高的负面影响。